Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma
Clinical trial NCT00826241 · COMPLETED
Trial details
- NCT number
- NCT00826241
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2018-07-31
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.